Gut-Brain Interaction Disorders Linked with Overlapping Conditions, Suggests Study
A recent prospective cross-sectional study published in the Indian Journal of Gastroenterology in April 2025 reveals that a striking 40.3% of patients with gut-brain interaction disorders (DGBIs) suffer from overlapping conditions. This complex overlap significantly diminishes their health-related quality of life and dramatically amplifies somatization compared to healthy individuals.
Despite their known negative impact on quality of life and somatization, detailed data on the prevalence and overlap of gut-brain interaction disorders (DGBIs) remain limited. To address this gap, Omesh Goyal and colleagues investigated the clinical burden and overlap patterns of these conditions in a northern Indian healthcare setting.
Therefore, in the prospective cross-sectional study, researchers screened 2,538 patients, ultimately enrolling 1,044 individuals with DGBIs and 1,021 healthy controls to compare clinical outcomes. To ensure accurate results, patients with organic gastrointestinal diseases, severe comorbidities, or incomplete records were strictly excluded.
Key Clinical Findings of the Study Includes:
High Overlap Prevalence: Researchers found that a substantial 40.3% of the patient cohort experienced overlapping DGBIs, with functional dyspepsia (FD) and functional esophageal disorders (FEsD) being the most frequently paired diagnoses at 23.9%.
Regional Gastrointestinal Involvement: Investigations revealed the gastroduodenal region was the most commonly affected area at 49.9%, sequentially followed by bowel disorders at 39.7% and esophageal complaints at 33.3%.
Dominant Individual Diagnoses: Analysis identified FD as the most prevalent individual condition affecting 44.4% of patients, followed sequentially by FEsD at 32.4%, functional constipation (FC) at 18%, and irritable bowel syndrome (IBS) at 16.1%.
Diminished Quality of Life: Assessments demonstrated that affected patients experienced significantly poorer HRQoL scores compared to HCs, plummeting substantially to 13.52 from the 19.1 healthy baseline.
Escalated Somatization Burden: Evaluations highlighted a stark increase in patient somatization severity, with scores soaring to 18.5 compared to merely 2.5 in the healthy matched cohort, a detriment further worsened by diagnostic overlaps.
The results suggest a profound clinical burden associated with the entire spectrum of DGBIs, conclusively demonstrating that the 41.1% of screened patients diagnosed with these conditions endure significantly compromised HRQoL and amplified psychological distress. Furthermore, these physiological and somatic detriments are remarkably intensified when functional conditions overlap, validating the severe overall impact on patient wellness.
Thus, the study concludes healthcare professionals should consider integrating a multidisciplinary care approach that routinely evaluates for potential diagnostic overlaps and comprehensively assesses the overall well-being of all DGBI patients to thoughtfully optimize clinical outcomes.
Although the provided source does not explicitly detail specific methodological limitations or future directives, the current cross-sectional findings organically inspire the gentle exploration of these complex multi-symptom overlaps within broader, multicenter clinical populations to continually enrich holistic patient care.
Reference
Goyal, O., Goyal, P., Goyal, M. K., Jain, K., Midha, V., & Sood, A. (2025). Overlap of ‘disorders of gut-brain interaction’ and their impact on quality of life and somatization in a tertiary care center- A cross-sectional study. Indian Journal of Gastroenterology, 44, 478–488.
